Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $69
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Nathan Treybeck maintains an Overweight rating on PROCEPT BioRobotics (NASDAQ:PRCT) and raises the price target from $67 to $69.
August 02, 2024 | 6:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Nathan Treybeck maintains an Overweight rating on PROCEPT BioRobotics and raises the price target from $67 to $69.
The Overweight rating and increased price target from a reputable analyst at Wells Fargo is likely to positively influence investor sentiment and drive short-term price appreciation for PROCEPT BioRobotics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100